According to Triton Market Research, the Global Surgical Site Infection Control Market report is sectioned by Procedure (Laparoscopy, Orthopedic Surgery, Cardiovascular, Obstetrics and Gynecology, Wound Closure, Plastic & Reconstructive Surgery, Thoracic Surgery, Microvascular, Urology, Neurosurgery, Other Procedures), Type of Infection (Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI), Industry Vertical (Hospitals, Ambulatory Surgical Centers), Product (Manual Reprocessors Solutions, Surgical Gloves, Disinfectants [Skin Disinfectants, Hand Disinfectants], Surgical Drapes, Skin Preparation Solutions, Surgical Irrigation, Surgical Scrubs, Hair Clippers, Medical Nonwovens, Other Products), and Regional Outlook (Middle East and Africa, Europe, Asia-Pacific, North America, Latin America).
The report highlights the Market Summary, Industry Outlook, Porter’s Five Forces Analysis, Market Maturity Analysis, Supply Chain Analysis, Regulatory Framework, Key Buying Impact Analysis, Key Market Strategies, Market Drivers, Challenges, Opportunities, Analyst Perspective, Competitive Landscape, Research Methodology and scope, Global Market Size, Forecasts & Analysis (2024-2032).
Triton’s analysis estimates that the global surgical site infection control market is set for robust growth at a CAGR of 5.21% during the forecast period 2024-2032.
A surgical site infection (SSI) occurs after surgery in the area where the procedure was performed. SSIs can be superficial, deep within the incision, or involve organs. Effective infection control is crucial for reducing these infections, ensuring patient safety, and meeting regulatory standards.
The growth of minimally invasive and outpatient surgical practices, a surge in surgical procedures, and technological advancements are expected to create novel opportunities for the surgical site infection control market. As advanced surgical techniques become more widespread, they reduce the physical trauma and recovery time associated with traditional surgeries, leading to an increase in the number of surgeries performed in outpatient settings. This shift heightens the need for effective infection control measures, as patients are discharged sooner and are more likely to develop infections outside of the hospital environment. As a result, there is a growing demand for innovative SSI prevention products, such as advanced wound dressings, antimicrobial sutures, effective sterilization processes, etc.
On the contrary, an increase in outpatient treatment, a surge in medical waste due to the use of disposable medical products, and insufficient awareness about HAIs hamper the SSI market’s expansion.
The Asia-Pacific is estimated to become the fastest-growing region in the surgical site infection control market. The significant growth is due to a combination of factors, including an increase in surgical procedures, rising awareness about infection control, and advancements in healthcare infrastructure. Countries such as China, India, and Japan are leading this expansion due to their large population and increasing healthcare expenditures. Additionally, the demand for innovative solutions, such as antimicrobial dressings, surgical drapes, and advanced sterilization techniques, is on the rise.
The major companies in the surgical site infection control market are American Polyfilm Inc, Ansell Limited, Belimed Life Science AG, 3M, Becton, Dickinson and Company (BD), Biomerieux SA, Getinge AB, Gama Healthcare, Johnson & Johnson, Kimberly-Clark Corporation, Stryker Corporation, Sotera Health LLC, and Steris Corporation.
The threat of new entrants is likely to be significant due to the rising acceptance and increased regulatory approvals of surgical products by the FDA and European authorities. For example, surgical masks, which protect surgeons from airborne particles and liquid contaminants, are regulated by organizations such as the CDC’s National Institute for Occupational Safety and Health (NIOSH) and the Occupational Safety and Health Administration (OSHA).
The global market for cosmetic bioactive ingredients is expected to advance at a C..
The global patient mechanical lift handling equipment market is estimated to grow ..
The global artificial blood vessels market will progress at a CAGR of 6.89% during..